374 related articles for article (PubMed ID: 8558195)
1. Uniform approach to risk classification and treatment assignment for children with acute lymphoblastic leukemia.
Smith M; Arthur D; Camitta B; Carroll AJ; Crist W; Gaynon P; Gelber R; Heerema N; Korn EL; Link M; Murphy S; Pui CH; Pullen J; Reamon G; Sallan SE; Sather H; Shuster J; Simon R; Trigg M; Tubergen D; Uckun F; Ungerleider R
J Clin Oncol; 1996 Jan; 14(1):18-24. PubMed ID: 8558195
[TBL] [Abstract][Full Text] [Related]
2. Risk- and response-based classification of childhood B-precursor acute lymphoblastic leukemia: a combined analysis of prognostic markers from the Pediatric Oncology Group (POG) and Children's Cancer Group (CCG).
Schultz KR; Pullen DJ; Sather HN; Shuster JJ; Devidas M; Borowitz MJ; Carroll AJ; Heerema NA; Rubnitz JE; Loh ML; Raetz EA; Winick NJ; Hunger SP; Carroll WL; Gaynon PS; Camitta BM
Blood; 2007 Feb; 109(3):926-35. PubMed ID: 17003380
[TBL] [Abstract][Full Text] [Related]
3. Prognostic significance of sex in childhood B-precursor acute lymphoblastic leukemia: a Pediatric Oncology Group Study.
Shuster JJ; Wacker P; Pullen J; Humbert J; Land VJ; Mahoney DH; Lauer S; Look AT; Borowitz MJ; Carroll AJ; Camitta B
J Clin Oncol; 1998 Aug; 16(8):2854-63. PubMed ID: 9704739
[TBL] [Abstract][Full Text] [Related]
4. Ploidy of lymphoblasts is the strongest predictor of treatment outcome in B-progenitor cell acute lymphoblastic leukemia of childhood: a Pediatric Oncology Group study.
Trueworthy R; Shuster J; Look T; Crist W; Borowitz M; Carroll A; Frankel L; Harris M; Wagner H; Haggard M
J Clin Oncol; 1992 Apr; 10(4):606-13. PubMed ID: 1548523
[TBL] [Abstract][Full Text] [Related]
5. High concordance from independent studies by the Children's Cancer Group (CCG) and Pediatric Oncology Group (POG) associating favorable prognosis with combined trisomies 4, 10, and 17 in children with NCI Standard-Risk B-precursor Acute Lymphoblastic Leukemia: a Children's Oncology Group (COG) initiative.
Sutcliffe MJ; Shuster JJ; Sather HN; Camitta BM; Pullen J; Schultz KR; Borowitz MJ; Gaynon PS; Carroll AJ; Heerema NA
Leukemia; 2005 May; 19(5):734-40. PubMed ID: 15789069
[TBL] [Abstract][Full Text] [Related]
6. Low numbers of CSF blasts at diagnosis do not predict for the development of CNS leukemia in children with intermediate-risk acute lymphoblastic leukemia: a Childrens Cancer Group report.
Gilchrist GS; Tubergen DG; Sather HN; Coccia PF; O'Brien RT; Waskerwitz MJ; Hammond GD
J Clin Oncol; 1994 Dec; 12(12):2594-600. PubMed ID: 7989934
[TBL] [Abstract][Full Text] [Related]
7. Clinical relevance of CD10 expression in childhood ALL. The Italian Association for Pediatric Hematology and Oncology (AIEOP).
Consolini R; Legitimo A; Rondelli R; Guguelmi C; Barisone E; Lippi A; Cantù-Rajnoldi A; Aricò M; Conter V; Cocito MG; Putti MC; Pession A; Masera G; Biondi A; Basso G
Haematologica; 1998 Nov; 83(11):967-73. PubMed ID: 9864914
[TBL] [Abstract][Full Text] [Related]
8. Pilot studies of species-specific chemotherapy of childhood acute lymphoblastic leukemia using genotype and immunophenotype.
Manera R; Ramirez I; Mullins J; Pinkel D
Leukemia; 2000 Aug; 14(8):1354-61. PubMed ID: 10942229
[TBL] [Abstract][Full Text] [Related]
9. Prognostic value of karyotypic analysis in children and adults with high-risk acute lymphoblastic leukemia included in the PETHEMA ALL-93 trial.
Ribera JM; Ortega JJ; Oriol A; Granada I; Hernández-Rivas JM; Parody R; Bethencourt C; Rivas C; Bastida P; del Potro E; González-Valentín ME; Moreno MJ; Besalduch J; Fernández-Calvo J; Tormo M; Arias J; Molinés A; Sanz MA; Maldonado J; Millá F; Feliu E; San Miguel JF;
Haematologica; 2002 Feb; 87(2):154-66. PubMed ID: 11836166
[TBL] [Abstract][Full Text] [Related]
10. The long-term results of childhood acute lymphoblastic leukemia at two centers from Turkey: 15 years of experience with the ALL-BFM 95 protocol.
Güneş AM; Oren H; Baytan B; Bengoa SY; Evim MS; Gözmen S; Tüfekçi O; Karapınar TH; Irken G
Ann Hematol; 2014 Oct; 93(10):1677-84. PubMed ID: 24863691
[TBL] [Abstract][Full Text] [Related]
11. Treatment of childhood acute lymphoblastic leukemia: results of Dana-Farber Cancer Institute/Children's Hospital Acute Lymphoblastic Leukemia Consortium Protocol 85-01.
Schorin MA; Blattner S; Gelber RD; Tarbell NJ; Donnelly M; Dalton V; Cohen HJ; Sallan SE
J Clin Oncol; 1994 Apr; 12(4):740-7. PubMed ID: 8151317
[TBL] [Abstract][Full Text] [Related]
12. [Analysis of clinical features and prognostic significance of childhood T-lineage acute lymphoblastic leukemia].
Zhang YL; Zhao WL; Nie SS; Guo DD; Ji ZH; Chai YH
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2011 Dec; 19(6):1496-500. PubMed ID: 22169311
[TBL] [Abstract][Full Text] [Related]
13. Role of cranial radiotherapy for childhood T-cell acute lymphoblastic leukemia with high WBC count and good response to prednisone. Associazione Italiana Ematologia Oncologia Pediatrica and the Berlin-Frankfurt-Münster groups.
Conter V; Schrappe M; Aricó M; Reiter A; Rizzari C; Dördelmann M; Valsecchi MG; Zimmermann M; Ludwig WD; Basso G; Masera G; Riehm H
J Clin Oncol; 1997 Aug; 15(8):2786-91. PubMed ID: 9256120
[TBL] [Abstract][Full Text] [Related]
14. Should adolescents with acute lymphoblastic leukemia be treated as old children or young adults? Comparison of the French FRALLE-93 and LALA-94 trials.
Boissel N; Auclerc MF; Lhéritier V; Perel Y; Thomas X; Leblanc T; Rousselot P; Cayuela JM; Gabert J; Fegueux N; Piguet C; Huguet-Rigal F; Berthou C; Boiron JM; Pautas C; Michel G; Fière D; Leverger G; Dombret H; Baruchel A
J Clin Oncol; 2003 Mar; 21(5):774-80. PubMed ID: 12610173
[TBL] [Abstract][Full Text] [Related]
15. Effective VCR/DEX pulse maintenance therapy in the KYCCSG ALL-02 protocol for pediatric acute lymphoblastic leukemia.
Okamoto Y; Koga Y; Inagaki J; Ozono S; Ueda K; Shimoura M; Itonaga N; Shinkoda Y; Moritake H; Nomura Y; Nakayama H; Hotta N; Hidaka Y; Shimonodan H; Suga N; Tanabe T; Nakashima K; Fukano R; Kawano Y
Int J Hematol; 2016 Feb; 103(2):202-9. PubMed ID: 26586463
[TBL] [Abstract][Full Text] [Related]
16. Prognostic significance of the CD10+CD19+CD34+ B-progenitor immunophenotype in children with acute lymphoblastic leukemia: a report from the Children's Cancer Group.
Uckun FM; Sather H; Gaynon P; Arthur D; Nachman J; Sensel M; Steinherz P; Hutchinson R; Trigg M; Reaman G
Leuk Lymphoma; 1997 Nov; 27(5-6):445-57. PubMed ID: 9477126
[TBL] [Abstract][Full Text] [Related]
17. Outcome and prognostic factors of acute lymphoblastic leukemia in children at the National Cancer Institute, Egypt.
Hussein H; Sidhom I; Naga SA; Amin M; Ebied E; Khairy A; Kamel A; El-Sharkawy N
J Pediatr Hematol Oncol; 2004 Aug; 26(8):507-14. PubMed ID: 15284589
[TBL] [Abstract][Full Text] [Related]
18. [Prognostic implication of DNA contents on long-term outcome of childhood acute lymphoblastic leukemia].
Tsurusawa M; Katano N; Aoyama M; Fujimoto T; Nishikawa K; Hatae Y; Miyake M; Kawakami K; Furuyama T; Iwai A; Horikoshi Y
Rinsho Ketsueki; 1997 Jul; 38(7):561-5. PubMed ID: 9267157
[TBL] [Abstract][Full Text] [Related]
19. Immunophenotypes and karyotypes of leukemic cells in children with Down syndrome and acute lymphoblastic leukemia.
Pui CH; Raimondi SC; Borowitz MJ; Land VJ; Behm FG; Pullen DJ; Hancock ML; Shuster JJ; Steuber CP; Crist WM
J Clin Oncol; 1993 Jul; 11(7):1361-7. PubMed ID: 8315434
[TBL] [Abstract][Full Text] [Related]
20. Clinical significance of translocation t(1;19) in childhood acute lymphoblastic leukemia in the context of contemporary therapies: a report from the Children's Cancer Group.
Uckun FM; Sensel MG; Sather HN; Gaynon PS; Arthur DC; Lange BJ; Steinherz PG; Kraft P; Hutchinson R; Nachman JB; Reaman GH; Heerema NA
J Clin Oncol; 1998 Feb; 16(2):527-35. PubMed ID: 9469337
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
